Safe, secure and effective deployment of digital health focused technology
January 6, 2025
It was a pleasure to welcome Stuart Harrison from ETHOS, who delivered our first 2025 Seminar Series with his talk,
"Effective deployment of digital health focused technology at scale".
Stuart has led the Clinical Safety movement in the NHS alongside some of the most prominent Clinical leaders for over 20 years. Stuart is now the co-founder & director of ETHOS, a company providing ethical services to the health industry.
Seminar Series Event: "Effective deployment of digital health focused technology at scale"
Date and Time:
15:00 – 16.00, Wednesday 29 January 2025
Location:
The Judy Dunn Room, Social Genetic and Developmental Psychiatry Building, Denmark Hill Campus, Memory Lane, London SE5 8AF
Registration: EPSRC DRIVE-Health students, alumni and wider King's College London research community. Please email
drive-health-cdt@kcl.ac.uk
to register interest.
Abstract: ETHOS will provide insight into the requirements for the safe, secure, and effective deployment of digital health focused technology at scale. Discussions concerning early research problem identification, health system challenges and taking research through to minimum viable product (MVP) and minimum marketable product (MMP). The objective is to highlight the benefit of earlier alignment with regulatory challenges to aid successful interventions and to demonstrate standards can be an enabler not a barrier to innovation.
Stuart Harrison has led the Clinical Safety movement in the NHS alongside some of the most prominent Clinical leaders for over 20 years. Stuart is now the co-founder & director of a company providing ethical services to the health industry. ETHOS Ltd was formed in 2014 as a result of a feasibility study completed in partnership with a large pharmaceutical company in the interests of furthering medical science / MedTech innovation. ETHOS was formed from subject matter experts in the compliance requirements for the NHS covering security, information governance, clinical safety, Medical Devices and General Data Protection Regulations. Stuart’s background is Engineering, particularly safety critical industries where safety has immediate risk to harm to system users or the wider general population. He was one of the original authors of the clinical safety standards.
An expert advisor (BSI UK) international safety, security, and effectiveness standards; leading this area since 2017 and creating a legacy from the widely recognised NHS clinical safety practises into the international health informatics industry. Stuart has significantly contributed to over 1000 health software systems being clinically assured and provided subject matter input to over 3000 service incidents with patient safety impact in the NHS. He led the creation of clinical risk management toolkits to enable self-certification across the industry for low-risk unregulated health software & ensuring they are compatible with new medical device regulations. A specialist advisor to NICE for medical technology and work closely with MHRA and other arm’s length bodies where patient safety and health software initiatives are needed. A steering group member and advisor to many professional institutions and organisations representing digital health; Stuart is helping to influence safety culture and methods across a number of domains. Stuart was co-author of the government’s Regulators Pioneer Fund bid to address the assurance of AI & machine learning in health software. Having successfully facilitated a £1M research grant being awarded to NHS Digital & MHRA. Digital Leader finalist – Digital City Awards 2021. Stuart is currently studying part time for a PhD at the University of Warwick on the subject of clinical decision supporting systems including safety concepts for emerging technology & complementary regulatory frameworks, the inclusion of mobile health data into safer decision making and exploring the lifecycle models of clinical decision supporting systems.
Share

We're pleased to announce that DRIVE-Health PhD student, Dr Hugh Logan-Ellis - a Diabetes and Endocrinology Registrar at King's and ex-Research Fellow in the Department of Medicine at Dalhousie University - will deliver our September Seminar Series. In his talk “Extracting Clinical Value from EHR Data: Challenges, Pitfalls, and Practical Lessons" , In his talk, Hugh will share what clinicians have taught him about the reality of working with Electronic Health Record data and what they genuinely need from #AI tools, rather than what researchers might think they should want. Hugh has learned that making the most clinically useful tool could matter more than theoretical perfection. He'll discuss some principles he's gathered to help create AI solutions that fit seamlessly into clinical workflows, which he hopes might help others bridge the gap between academic research and genuine patient benefit. Using his PhD research on creating a single unit of health from #EHR data as a central example, Hugh will explore broader challenges: the messiness of real-world clinical data, the proliferation of unused risk scores, and why so many promising algorithms never make it past publication. These insights aim to help researchers develop tools that won't just die in papers, but have a real chance of improving clinical care. Seminar Series Event: " Extracting Clinical Value from EHR Data: Challenges, Pitfalls, and Practical Lessons" Date and Time: Thursday 25 September 2025, 12:00 – 13.00 hrs (BST) Location: The Judy Dunn Room, SGDP Building, Denmark Hill Campus, London, SE5 8AF Attendance: Mandatory for all DRIVE-Health students, therefore please accept the calendar invitation. Registration: Alumni and wider King's College London research community all welcome - please email drive-health-cdt@kcl.ac.uk to let us know if you would like to attend. Abstract: Picture the scene: It's Saturday morning, you're the senior resident doctor on call in a busy hospital, and you have a 40-page list of patients due for review. Half of your junior colleagues have called in sick, and you know you can't possibly see everyone. How do you decide who needs to be seen most urgently? The information to make these decisions is in the electronic health records, but accessing it quickly means opening each patient's chart individually. My PhD tries to tackle this problem: could we use an algorithm to compress scattered clinical data into a single, practical number? This question has led me on an interesting journey. I've spoken with clinicians from around the world about how they decide who is "sickest," discovering a surprising variety of terms for essentially the same idea and realising we might need more than one measure. My research has taken me to Canada to collaborate with Professor Kenneth Rockwood OC, whose groundbreaking work on frailty measurement has significantly shaped clinical practice worldwide. Working alongside him has given me valuable insights into why some academic ideas successfully transform patient care, while others remain confined to journals. As I explored increasingly sophisticated approaches to measure sickness, from simple laboratory-based indices to complex machine learning models, I stumbled across a key insight. Supervised machine learning can hindered by retrospective health data because when sick patients are successfully treated, they don’t have poor outcomes. This isn't just a quirky finding relevant to my PhD; it has broader implications for using a supervised paradigm on retrospective data whenever effective treatments are already in place. Bio Hugh is a resident medical doctor specialising in Internal Medicine and Diabetes and Endocrinology, working on his PhD at King's College London. His research focuses on measuring patient health status using electronic health records, drawing on his experience working across various healthcare settings in the UK and internationally.

We’re pleased to announce that Dr Petroula Laiou from King's College London , will deliver our May Seminar Series with her talk, "Bridging the Gap: Turning Academic Research into Clinical Innovation " . Petroula will share her journey of translating cutting-edge academic research into a mission-driven MedTech company. The spinout is pioneering a novel approach to forecasting and preventing seizures in people with drug-resistant epilepsy - an innovation rooted in years of interdisciplinary work at the intersection of clinical neuroscience, signal processing, and artificial intelligence. Dr. Laiou will take the audience through the full translational pathway: from identifying an unmet clinical need, designing and analysing first-in-human studies, and developing a seizure prediction algorithm, to securing translational funding, navigating the intellectual property landscape, and filing an international patent (PCT/GB2024/052456). She will reflect on key lessons learned during her time in the King’s MedTech Accelerator Programme - where the team won the Best Innovation award - and share insights on building bridges between academia and industry, shaping a commercialization strategy, and transitioning from researcher to entrepreneur. The talk will also highlight the challenges and rewards of launching a spinout in the healthcare sector and offer practical advice for PhD students and early-career researchers considering the entrepreneurial route. Seminar Series Event: "Bridging the Gap: Turning Academic Research into Clinical Innovation" Date and Time: Wednesday 7 May 2025, 15:00 – 16.00 hrs (BST) Location: The Lorna Wing Room, SGDP Building, Denmark Hill Campus, London, SE5 8AF Attendance: Mandatory for all DRIVE-Health students, therefore please accept the calendar invitation. Registration: Alumni and wider King's College London research community all welcome - please email drive-health-cdt@kcl.ac.uk to let us know if you would like to attend. Dr. Petroula Laiou is a Research Fellow in Predictive Modelling and Clinical Neuroscience at King’s College London. With a background in mathematics, computational physics, and a PhD in signal analysis, her research bridges computer science, neuroscience, and machine learning. Her work focuses on developing predictive models and digital biomarkers for neurological and psychiatric disorders, including epilepsy and depression. Dr. Laiou led the development of a novel seizure forecasting algorithm using intracranial EEG and cortical responses to electrical stimulation—research that led to the filing of an international patent (PCT/GB2024/052456). She is the recipient of multiple research grants, including an MRC award as Principal Investigator, and her translational work was recognised by the King’s MedTech Accelerator Programme, where her team won the Best Innovation award. She has authored over 40 peer-reviewed publications, presented at major international conferences, and actively contributes to interdisciplinary collaborations across academia, hospitals, and industry.